Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research

Impaired cognition is often overlooked in the clinical management of depression, despite its association with poor psychosocial functioning and reduced clinical engagement. There is an outstanding need for new treatments to address this unmet clinical need, highlighted by our consultations with indi...

Descripción completa

Detalles Bibliográficos
Autores principales: Colwell, Michael J., Tagomori, Hosana, Chapman, Sarah, Gillespie, Amy L., Cowen, Philip J., Harmer, Catherine J., Murphy, Susannah E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671959/
https://www.ncbi.nlm.nih.gov/pubmed/36396622
http://dx.doi.org/10.1038/s41398-022-02249-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671959/
https://www.ncbi.nlm.nih.gov/pubmed/36396622
http://dx.doi.org/10.1038/s41398-022-02249-6

Ejemplares similares